Optimizing care for women going through menopause


Menopause can be associated with many different symptoms, ranging from vasomotor symptoms and sleep disturbances to urogenital symptoms and mood/cognitive changes, among others.1-3 These symptoms can have a profound impact on a woman’s daily life and activities, as well as on sexual and mental health.2-4 They may also lead to enduring long-term health impacts that increase the risk of cardiovascular disease, bone loss, and psychiatric illnesses.5,6 Understanding the individual experience of each woman, including both short-term symptoms and long-term risks, is critical to optimally managing menopause symptoms and improving health outcomes.

Menopause workstream objectives

  • Highlight Impact
    To highlight the impact of menopause on short- and long-term health outcomes across all critical audiences
  • Inform Women
    To inform women to better understand menopause and encourage them to seek care when symptoms impact quality of life
  • Provide Health
    To provide health care professionals with accurate, evidence-based information to facilitate individualized care
  • Drive conversation
    To drive the menopause conversation, empowering women and health care professionals and enabling shared decision-making to meet each woman’s individual care needs

  • Enable Access
    To enable access and awareness of evidence-based treatment options via optimal care pathways



-

Upcoming resources

Through collective expertise in women’s health, as the Women’s Health Academy, we will build unique resources that capture the many individual characteristics and risks that will inform targeted care, including investigations and interventions at a menopause consultation. Stay tuned for these resources, which will capture multidisciplinary considerations and support individualized approaches.


    Referencesexpand_less
    • 1
      Nappi RE et al. Menopause 2021; 28(8): 875–882.
    • 2
      Cucinella L, Tiranini L, Nappi RE. Best Pract Res Clin Endocrinol Metab 2024; 38(1): 101822.
    • 3
      Davis SR et al. Cell 2023; 186(19): 4038–4058.
    • 4
      Whiteley J et al. J Womens Health (Larchmt) 2013; 22(11): 983–990.
    • 5
      Andrews R et al. Maturitas 2024; 190: 108130.
    • 6
      Nappi RE et al. Lancet Diabetes Endocrinol 2022; 10(6): 442–456.